GLAXO responds to drug court Rawalpindi judgment
In a notification sent to PSX on 24/04/2024, GlaxoSmithKline Pakistan Limited (GLAXO) has announced its legal position on the GLAXO drug case judgment.
We would like to inform you that the Drug Court Rawalpindi has passed judgement dated April 22, 2024, in Case Judicial No. 4229/DC/Rwp/22 against the current and former officers of GSK under the Drugs Act 1976 related to the provision of sub-standard drugs.
GSK as well as the officers impleaded in the proceedings hereby deny any sort of wrong doing in the matter and are taking immediate steps to challenge the aforementioned judgment before the appellate forum. We would also like to inform you that GSK will keep all stakeholders abreast of any significant updates in this regard.
📢 Announcement: We're Moving to Discord – Join Us There!
Hi everyone! 👋
To improve your experience and offer additional features, we’re moving our community from WhatsApp to Discord!
Here’s what you’ll get on Discord:
✅ Research Reports Channel – Access a regularly updated compilation of valuable research reports
✅ PSX24/7 Bot – Ask anything about the PSX and get instant insights powered by KSEStocks historical data
✅ Organized Channels – Separate spaces for discussions, news, reports, and more
✅ Better Notifications – Control what you see and when
✅ Smoother Interaction – Easier to follow and participate in conversations
✅ Organized trading ideas - trading ideas that you can discuss and keep track ofJoin now 👉 https://discord.gg/kST9hWjS
The shares of GLAXO were last trading at Rs. 98.89 today.
⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →
Leave a Reply